[go: up one dir, main page]

EA199800822A1 - Способ лечения избыточной агрессии - Google Patents

Способ лечения избыточной агрессии

Info

Publication number
EA199800822A1
EA199800822A1 EA199800822A EA199800822A EA199800822A1 EA 199800822 A1 EA199800822 A1 EA 199800822A1 EA 199800822 A EA199800822 A EA 199800822A EA 199800822 A EA199800822 A EA 199800822A EA 199800822 A1 EA199800822 A1 EA 199800822A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treating excessive
excessive aggression
aggression
treating
olanzapine
Prior art date
Application number
EA199800822A
Other languages
English (en)
Other versions
EA000741B1 (ru
Inventor
Чарльз М. мл. Бисли
Пьер В. Тран
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA199800822A1 publication Critical patent/EA199800822A1/ru
Publication of EA000741B1 publication Critical patent/EA000741B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Pyrane Compounds (AREA)

Abstract

Данное изобретение обеспечивает способ лечения чрезвычайной агрессии, предусматривающий введение эффективного количества оланзапина пациенту, нуждающемуся в таком лечении.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA199800822A 1996-03-11 1996-12-04 Способ лечения избыточной агрессии EA000741B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1312796P 1996-03-11 1996-03-11
PCT/US1996/019573 WO1997033584A1 (en) 1996-03-11 1996-12-04 Method for treating excessive aggression

Publications (2)

Publication Number Publication Date
EA199800822A1 true EA199800822A1 (ru) 1999-02-25
EA000741B1 EA000741B1 (ru) 2000-02-28

Family

ID=21758447

Family Applications (1)

Application Number Title Priority Date Filing Date
EA199800822A EA000741B1 (ru) 1996-03-11 1996-12-04 Способ лечения избыточной агрессии

Country Status (22)

Country Link
EP (1) EP0900085B1 (ru)
JP (1) JP2000506858A (ru)
KR (1) KR19990087716A (ru)
CN (1) CN1124847C (ru)
AT (1) ATE306269T1 (ru)
AU (1) AU719517B2 (ru)
BR (1) BR9612549A (ru)
CA (1) CA2248753C (ru)
CZ (1) CZ296579B6 (ru)
DE (1) DE69635282T2 (ru)
DK (1) DK0900085T3 (ru)
EA (1) EA000741B1 (ru)
ES (1) ES2249789T3 (ru)
HU (1) HUP9903685A3 (ru)
IL (1) IL126157A (ru)
NO (1) NO323579B1 (ru)
NZ (1) NZ325035A (ru)
PL (1) PL186975B1 (ru)
RO (1) RO117347B1 (ru)
TR (1) TR199801799T2 (ru)
UA (1) UA57727C2 (ru)
WO (1) WO1997033584A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000030648A1 (en) * 1998-11-23 2000-06-02 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
CA2351718A1 (en) 1998-11-23 2000-06-02 Sepracor Inc. Desmethylolanzapine compositions and methods
AU757870B2 (en) * 1998-11-23 2003-03-06 Sepracor, Inc. Pharmaceutical compositions containing olanzapine-N-oxide

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4595535A (en) * 1983-06-06 1986-06-17 Ciba-Geigy Corporation Diazacycloalkyl-1,2,4-triazolo[2,3-c][1,3]benzodiazepines useful as neuroleptic and/or antihistaminic agents
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5605897A (en) * 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
JPH11506096A (ja) * 1995-05-30 1999-06-02 イーライ・リリー・アンド・カンパニー 認識機能不全を処置する方法

Also Published As

Publication number Publication date
PL328949A1 (en) 1999-03-01
NZ325035A (en) 2001-06-29
NO984198L (no) 1998-11-02
CZ296579B6 (cs) 2006-04-12
CN1213969A (zh) 1999-04-14
EP0900085B1 (en) 2005-10-12
HUP9903685A3 (en) 2001-12-28
BR9612549A (pt) 1999-07-20
TR199801799T2 (xx) 1999-01-18
RO117347B1 (ro) 2002-02-28
UA57727C2 (ru) 2003-07-15
HUP9903685A2 (hu) 2000-03-28
CA2248753A1 (en) 1997-09-18
NO984198D0 (no) 1998-09-11
IL126157A0 (en) 1999-05-09
NO323579B1 (no) 2007-06-11
CA2248753C (en) 2008-11-18
WO1997033584A1 (en) 1997-09-18
JP2000506858A (ja) 2000-06-06
ATE306269T1 (de) 2005-10-15
AU719517B2 (en) 2000-05-11
EP0900085A1 (en) 1999-03-10
ES2249789T3 (es) 2006-04-01
CN1124847C (zh) 2003-10-22
DE69635282T2 (de) 2006-04-20
DE69635282D1 (de) 2006-02-23
EA000741B1 (ru) 2000-02-28
EP0900085A4 (en) 2000-12-13
DK0900085T3 (da) 2006-01-30
AU1284697A (en) 1997-10-01
PL186975B1 (pl) 2004-04-30
IL126157A (en) 2002-09-12
CZ290598A3 (cs) 1999-09-15
KR19990087716A (ko) 1999-12-27

Similar Documents

Publication Publication Date Title
EA199800667A1 (ru) Новые фенантридины
EA199800857A1 (ru) Композиция для снятия боли и способ снятия боли
EA200100572A1 (ru) Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии
EA199800104A1 (ru) Способ лечения диабета
EA199900758A1 (ru) Малые молекулы, полезные при лечении воспалительных заболеваний
EA199800866A1 (ru) Способ снятия боли
EA199800864A1 (ru) Способ лечения при боли, вызванной мигренью
EA200100133A1 (ru) Оксазолидиноны для лечения инфекционных болезней глаз
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
BR9708027A (pt) Métodos de tratamento ou prevenção de cistite entersticial
EA199800535A1 (ru) Способ лечения боли
EA199800819A1 (ru) Способ лечения биполярного расстройства
EA199800822A1 (ru) Способ лечения избыточной агрессии
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
EA199800821A1 (ru) Способ лечения аутизма
ID27052A (id) Pengobatan arthritis dan keadaan-keadaan lain yang sekupa
EA199800818A1 (ru) Способ лечения бессонницы
EA199900174A1 (ru) Способ лечения биполярного расстройства
BR9708037A (pt) Método para o tratamento de abuso de substância
ATE268170T1 (de) Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
ATE225181T1 (de) Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen
EA199800820A1 (ru) Способ лечения злоупотребления лекарственными средствами
EA200101043A1 (ru) Способ лечения неврологических или нейропсихиатрических расстройств
UA43389C2 (uk) Спосіб зниження рівнів кальцію у сироватці

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU